Article - Issue 55
Predictive AI and ML Models in Drug Development
Article - Issue 55
GenAI's Impact on Reshaping the Pharma Industry
Article - Issue 55
The AI Revolution in Pharma
Article - Issue 55
Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance
Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration
Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China
ILiAD Biotechnologies LLC a biotechnology company focused on combating diseases caused by Bordetella
Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient at the Institute of Oncology Davidoff Center Rabin...
GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type
Hyundai Bioscience which is preparing for a dengue fever basket clinical trial in Brazil announced on the th that it has successfully developed a multitreatment drug for mosquitoborne viral infections
Capricor Therapeutics a biotechnology company developing transformative cell and exosomebased therapeutics for the treatment of rare diseases today announced
Charles River Laboratories International Inc and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and manufacturing
BioAI an emerging biotech company applying multimodal artificial intelligence to novel biomarker
Bota Bio a global industrial biotechnology company specializing in sustainable biomanufacturing solutions and NHU a global leader in the fine chemical industry have announced the successful commercialization
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd with its subsidiary As part of this merger Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliate...
Incheon, South Korea
Suntec Convention & Exhibition Centre, Singapore
Basel, Switzerland
Boston, MA, USA
Singapore
Tokyo, Japan
Boston, MA, USA
Jakarta Barat, Indonesia
Professor, Department of Pharmaceutics, St. Paul's College of Pharmacy
Professor, Department of Pharmaceutical Chemistry, Sri Shivani College of Pharmacy
Professor, Department of Pharmacology, St.Paul's College of Pharmacy
President, Global Critical Care, Venus Remedies Ltd, and CEO, Venus Medicine Research Centre
Associate Professor and the Head of Career Services and Placement at the School of Pharmacy, Dr. Vishwanath Karad MIT-WPU
Assistant Manager - Medical Affairs and Pharmacovigilance, Unichem Laboratories Ltd.
Chief Medical & Scientific Officer
Scientific progress depends upon collaboration iPS cell technology is at the forefront of pharmaceutical innovation and Takeda strives to bring innovative treatments to patients Both Takeda and CiRA have the common goal of providing patients and healthcare professionals with innovative new treatmentsMycobacterium tuberculosis Mtbis one of the major infectious diseases posing a major threat to many developing countries including India It has been a daunting task for researchers and scientists to design and develop drugs that possess the potential to inhibit the disease in a specific manner without exhibiting side effects in humans Presently there are four drugs
AbstractDespite being one of the first antitubercular agents identified isoniazid INH is still the most prescribed drug for prophylaxis and tuberculosis TB treatment and together with rifampicin the pillars of current chemotherapy A high percentage of isoniazid resistance is linked to mutations in the prodrug activating enzyme KatG so the discovery of di
AbstractPharmaceutical companies have taken a long time to start using social media in the first place but the industry is still struggling to fully embrace the digital space There are now more than two billion active social media users almost a third of the worlds population Customers are talking about health on the internet and in recent years s
Eli Lilly and Company in combination with Boehringer Ingelheim has developed Jardiance a novel therapy to treat patients with heart failure with preserved ejection fraction HFpEF Jardiance is used to lower the blood sugar levels along with diet and exercise in adults with type diabetes lessens the risk of cardiovascular
In the European Union a network of approximately regulatory authorities from the European Economic Area countries the European Commission and European Medicines Agency form the basis of the European regulatory system
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster
